Danaher Corp (DHR)
248.41
+1.01
(+0.41%)
USD |
NYSE |
May 07, 13:12
Danaher Enterprise Value: 194.38B for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 194.38B |
| May 03, 2024 | 195.11B |
| May 02, 2024 | 193.97B |
| May 01, 2024 | 194.01B |
| April 30, 2024 | 193.81B |
| April 29, 2024 | 193.95B |
| April 26, 2024 | 193.78B |
| April 25, 2024 | 193.20B |
| April 24, 2024 | 196.61B |
| April 23, 2024 | 198.61B |
| April 22, 2024 | 186.00B |
| April 19, 2024 | 185.58B |
| April 18, 2024 | 186.21B |
| April 17, 2024 | 188.43B |
| April 16, 2024 | 189.13B |
| April 15, 2024 | 188.63B |
| April 12, 2024 | 188.84B |
| April 11, 2024 | 191.84B |
| April 10, 2024 | 193.23B |
| April 09, 2024 | 196.14B |
| April 08, 2024 | 192.03B |
| April 05, 2024 | 192.05B |
| April 04, 2024 | 190.29B |
| April 03, 2024 | 192.10B |
| April 02, 2024 | 193.28B |
| Date | Value |
|---|---|
| April 01, 2024 | 194.65B |
| March 31, 2024 | 196.08B |
| March 28, 2024 | 197.47B |
| March 27, 2024 | 196.77B |
| March 26, 2024 | 196.54B |
| March 25, 2024 | 196.05B |
| March 22, 2024 | 201.23B |
| March 21, 2024 | 200.72B |
| March 20, 2024 | 198.92B |
| March 19, 2024 | 200.45B |
| March 18, 2024 | 198.77B |
| March 15, 2024 | 197.23B |
| March 14, 2024 | 200.06B |
| March 13, 2024 | 201.64B |
| March 12, 2024 | 199.97B |
| March 11, 2024 | 199.75B |
| March 08, 2024 | 200.41B |
| March 07, 2024 | 200.51B |
| March 06, 2024 | 199.61B |
| March 05, 2024 | 200.71B |
| March 04, 2024 | 202.05B |
| March 01, 2024 | 201.81B |
| February 29, 2024 | 199.79B |
| February 28, 2024 | 201.69B |
| February 27, 2024 | 201.06B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
78.42B
Minimum
Mar 23 2020
232.40B
Maximum
Dec 30 2021
167.17B
Average
180.65B
Median
Enterprise Value Benchmarks
| Quest Diagnostics Inc | 19.42B |
| Natera Inc | 11.37B |
| Delcath Systems Inc | 124.48M |
| CytoSorbents Corp | 41.40M |
| Progyny Inc | 2.755B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.088B |
| Revenue (Quarterly) | 5.796B |
| Total Expenses (Quarterly) | 4.484B |
| EPS Diluted (Quarterly) | 1.45 |
| Gross Profit Margin (Quarterly) | 60.16% |
| Profit Margin (Quarterly) | 18.77% |
| Earnings Yield | 2.38% |
| Operating Earnings Yield | 2.59% |
| Normalized Earnings Yield | 2.533 |